Phase 1 Chronic kidney disease trials recruiting now

All Chronic kidney disease trials, every phase

Other phases for Chronic kidney disease

Phase 1 Chronic kidney disease trials

• A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
  NCT07348237 · Phase: Phase 1 · Ages: 24 Years to 85 Years · Sex: All (male and female) · 3 locations
• A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
  NCT06310967 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 6 locations
• A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
  NCT07619820 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus
  NCT07619157 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 2 locations
• A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
  NCT07275788 · Phase: Phase 1 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
  NCT07559396 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
  NCT06749457 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 44 locations
• A Study to Evaluate the Safety, Tolerability and PK of SK-08
  NCT07021157 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
  NCT07231679 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
  NCT07024823 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 10 locations
• A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
  NCT06721143 · Phase: Phase 1, Phase 2 · Ages: 35 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Study to Learn About How a New Nurandociguat Tablet is Absorbed and Processed in the Body Compared to an Old Tablet and How Food Affects the Way the New Tablet is Absorbed and Processed in the Body
  NCT07722585 · Phase: Phase 1 · Ages: 18 Years to 58 Years · Sex: All (male and female) · 1 location
• A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
  NCT07262333 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
  NCT04392206 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Adding Urea to the Final Dialysis Fluid
  NCT06366230 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
  NCT07572890 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
  NCT06741072 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Breakthrough - T1DM and Chronic Kidney Disease
  NCT07592000 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
  NCT07053462 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 85 Years · Sex: All (male and female) · 1 location
• Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
  NCT05525507 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Demethylating Agent Azacitidine on Prevention of Acute Kidney Injury-chronic Kidney Disease Continuum
  NCT05325099 · Phase: Phase 1, Phase 2 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
  NCT07607197 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Intradialytic Exercise Combined With Creatine Monohydrate in Patients With Chronic Kidney Disease Undergoing Hemodialysis.
  NCT07666815 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
  NCT06434363 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial
  NCT06863194 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
  NCT07045467 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Renal Impairment Study for Oral EC5026
  NCT07694544 · Phase: Phase 1 · Ages: 55 Years and older · Sex: All (male and female) · 1 location
• Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
  NCT06917950 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
  NCT06903559 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease
  NCT07483372 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD
  NCT05018845 · Phase: Phase 1 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
  NCT05027906 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 9 locations
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
  NCT07235059 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Study of BHV-1400 in IgA Nephropathy
  NCT07054684 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 15 locations
• Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
  NCT05287945 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
  NCT06878560 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 70 Years · Sex: All (male and female) · 2 locations
• Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
  NCT07224763 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 70 Years · Sex: All (male and female) · 1 location
• Sympatholysis in Chronic Kidney Disease
  NCT02411773 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi
  NCT06836206 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.